Assignee
MCKINNEY ANTHONY ALEXANDER
US·0 granted patents·12 pending applications·0 citations·filing 2011–2020
Top patents by PatentIndex Score
12 records- 0169US2021046044A1Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disordersMCKINNEY ANTHONY ALEXANDER·Filed 2020·Application pending·0 cites
- 0265US2021161863A1Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmittersMCKINNEY ANTHONY ALEXANDER·Filed 2020·Application pending·0 cites
- 0362US2014315892A1Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disordersMCKINNEY ANTHONY ALEXANDER·Filed 2014·Application pending·0 cites
- 0461US2018296527A1Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disordersMCKINNEY ANTHONY ALEXANDER·Filed 2017·Application pending·0 cites
- 0558US2017216251A1Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disordersMCKINNEY ANTHONY ALEXANDER·Filed 2016·Application pending·0 cites
- 0658US2019358199A1Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmittersMCKINNEY ANTHONY ALEXANDER·Filed 2018·Application pending·0 cites
- 0755US2014039029A1Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmittersMCKINNEY ANTHONY ALEXANDER·Filed 2013·Application pending·0 cites
- 0855US2018256542A1Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmittersMCKINNEY ANTHONY ALEXANDER·Filed 2017·Application pending·0 cites
- 0951US2012258994A1Preparation and Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane In The Treatment of Conditions Affected by Monoamine NeurotransmittersMCKINNEY ANTHONY ALEXANDER·Filed 2011·Application pending·0 cites
- 1051US2013123238A1Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane to treat addictive and alcohol-related disordersMCKINNEY ANTHONY ALEXANDER·Filed 2012·Application pending·0 cites
- 1144US2017209415A1Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive disorders including nicotine addictionMCKINNEY ANTHONY ALEXANDER·Filed 2016·Application pending·0 cites
- 1240US2016346249A1Use of amitifadine, (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in methods and compositions with enhanced efficacy and reduced metabolic side effects and toxicity for treatment of depression and other central nervous system disorders and conditions affected by monoamine neurotransmittersMCKINNEY ANTHONY ALEXANDER·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MCKINNEY ANTHONY ALEXANDER files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →